Advertisement

Topics

Companies Related to "An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Trea∨derfield=score∨derval=DESC" [Most Relevant Company Matches] [Advanced Search Results] RSS

18:53 EDT 15th July 2019 | BioPortfolio

Here are the most relevant search results for "An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Trea∨derfield=score∨derval=DESC" found in our extensive corporate database of over 50,000 company records.

Showing "Efficacy Safety Study Fedratinib Compared Best Available Therapy" Companies 1–25 of 3,200+

Thursday 11th July 2019

Aimmune Therapeutics Inc.

Aimmune Therapeutics, Inc., is a clinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The company’s Characterized Oral Desensitization ImmunoTherapy (CODIT™) approach is intended to achieve meaningful levels of protection by desensitizing patients with defined, precise amounts of key allergens. Aimmu...


Tuesday 9th July 2019

Dermatology Times®

A multimedia platform for dermatologists, Dermatology Times® provides regulatory and clinical updates, as well as discussion on cost-effective practice management solutions. Dermatology Times® helps dermatology professionals grow their knowledge and advance their practice to improve patient care by providing them with the latest news and trends in dermatologic procedures, therapy, technolog...

Annexon Biosciences

Annexon’s pipeline of novel therapies includes two clinical-stage product candidates, ANX005, a monoclonal antibody, and ANX007, a fragmented monoclonal antibody, as well as other compounds in preclinical development. ANX005 is currently in a Phase 1/2 study in patients with Guillain-Barre Syndrome (GBS). Annexon also plans to evaluate ANX005 in complement-mediated neurodegenerative disorder...


Monday 8th July 2019

ATI Physical Therapy

ATI is a privately held, nationally recognized healthcare company, specializing in outpatient rehabilitation and adjacent healthcare services. With a focus on delivering a remarkable experience to every patient, every day, ATI has more than 800 locations from coast to coast. ATI was named “Best Physical Therapy Practice in the Nation” by ADVANCE magazine and was one of the first physica...

Wednesday 3rd July 2019

Kaycha Group LLC

At Kaycha Group, we apply science and technology with our global resources to bring services to the market that extend and significantly improve the efficacy of patient and product data in the cannabis industry. We strive to set the standard for quality, safety and value in the discovery, development and execution of our services. Our national portfolio includes testing services for marijuana and...

Bioscience Association Manitoba

Read the study here: https://www.biomb.ca/news/reports/561/2019-bam-industry-profile-study

Monday 1st July 2019

Sangamo Therapeutics, Inc.

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, in vivo genome editing and gene regulation. For more information about Sangamo, visit www.sangamo.com

Friday 28th June 2019

Airway Safety Movement

Airway Safety Movement was founded by Dr. Art Kanowitz in 2018 to educate and eliminate complications related to airway management, including failed intubation, ventilator associated pneumonia (VAP), tube mal-positioning and unplanned extubation, unrecognized esophageal intubation and pressure ischemia. The nonprofit is working to create a comprehensive and sustainable system for reliability in a...

Promedica International

Promedica International is a provider of CRO services to themedical device, biotech and pharmaceutical industries. Specializing in projectsinvolving innovative technology, our experienced staff and ISO-certified processesare the primary factors enabling us to consistently provide services highly regarded by our clients and their related study teams

Newron Pharmaceutical S.p.A.

Newron (SIX: NWRN) is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The company is headquartered in Bresso near Milan, Italy. Xadago® (safinamide) has received marketing authorization for the treatment of Parkinson’s disease in the European Union, Switzerland, the US, Australia, Canada, Br...

Wednesday 26th June 2019

Cognito Therapeutics

Cognito Therapeutics is a clinical-stage medical device company developing a non-invasive, in-home neurostimulation therapy platform based on a discovery from founders Professors Li-Huei Tsai and Ed Boyden at MIT, who showed a profound treatment response in mice using gamma entrainment stimulation (GENUS). Their research – published in the journals Nature, Cell and Neuron – showed that ...

Tuesday 25th June 2019

California Protons Cancer Therapy Center

California Protons’ intensity-modulated pencil beam scanning technology is a highly precise form of cancer radiation treatment that enables doctors to selectively target tumors with high-dose radiation while sparing healthy tissue. California Protons’ pencil beam scanning technology precisely delivers proton radiation treatment within 2 millimete...

Thursday 20th June 2019

Smoothwall

Smoothwall empowers schools to digitally safeguard the students in their care with next-generation web filtering, firewall, digital monitoring, classroom and record management solutions. Smoothwall solutions are engineered to address the safety and well-being of students, the self-sufficiency needs of teachers, and the cost-efficiency needs of school districts. They are designed to keep schools o...

Vayyar Imaging, Ltd.

Vayyar Imaging is a global leader in 4D imaging technology, providing highly advanced sensors to a wide variety of industries including automotive, smart home, robotics, retail and medical. The company’s sensors can see through walls and objects and track and map everything happening in an environment in real-time, all while maintaining privacy. Utilizing a state-of-the-art embedded chip and...

Tuesday 18th June 2019

F-star Therapeutics Ltd.

F-star is a leading clinical-stage biopharmaceutical company delivering tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumour immune evasion, the Company’s goal is to offer patients greater and more durable benefits than current immuno-oncology treatments. Through its proprietary te...

Monday 17th June 2019

IVERIC bio, Inc.

IVERIC bio is a biotechnology company with a focus on the discovery and development of novel gene therapy solutions to treat orphan inherited retinal diseases with unmet medical needs. Vision is Our Mission. For more information on the Company’s gene therapy and other programs, please visit www.ivericbio.com.

Mycovia Pharmaceuticals, Inc

Mycovia Pharmaceuticals has a passion for developing breakthrough therapies in areas of unmet medical need. Our lead product candidate, VT-1161 (oteseconazole), is a novel, oral therapy designed to have greater selectivity, fewer side effects and improved potency than current treatment options. It received FDA Qualified Infectious Disease Product and Fast-...

Thursday 13th June 2019

BioCell Technology, LLC

BioCell Collagen® is a clinically tested branded dietary ingredient that promotes active joints, youthful-looking skin, and healthy connective tissues. BioCell Collagen® contains a patented composition of naturally occurring hydrolyzed collagen type II peptides, chondroitin sulfate and hyaluronic acid in a highly absorbable matrix form that has been the ...

Wednesday 12th June 2019

IMV IMV Inc.

IMV Inc. is a clinical stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. IMV is pioneering a new class of immunotherapies based on the Company’s proprietary drug delivery platform. This patented technology leverages a ...

Tuesday 11th June 2019

Ironshore Pharmaceuticals Inc.

The effectiveness of JORNAY PM was established in two separate Pivotal Phase III, multicenter, randomized, double-blind, placebo-controlled studies conducted in a total of 278 pediatric patients aged 6 to 12 years with a diagnosis of ADHD per DSM-5 criteria. In addition to the traditional scales that assess efficacy in ADHD clinical trials such as the Swan...

AlloVir

AlloVir (formerly ViraCyte), founded in 2013 by researchers at Baylor College of Medicine’s Center for Cell and Gene Therapy, is the leader in the development of novel cell therapies with a focus on restoring natural T-cell immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The company’s...

Wednesday 5th June 2019

OncoMyx Therapeutics

OncoMyx Therapeutics, a startup launched from Arizona State University (ASU), develops oncolytic immunotherapies based on the myxoma virus (MYXV) platform to orchestrate an immune response and treat cancer. Successful immuno-oncology (IO) cancer treatment generally requires combination therapy, and oncolytic viruses (OVs) have emerged as a safe and effecti...

Enzyvant

Enzyvant, a wholly owned subsidiary of Roivant Sciences, is a biotechnology company focused on developing transformative therapies for patients with rare diseases. Enzyvant leverages the Roivant platform to develop therapies that address high unmet medical needs while driving greater efficiency in research, clinical development, and commercialization. The ...

Tuesday 4th June 2019

Prevail Therapeutics Inc.

Prevail Therapeutics is a gene therapy company leveraging breakthroughs in human genetics with the goal of developing and commercializing disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases. Prevail was founded by Dr. Abeliovich in 2017, through a collaborative effort with The Silverstein Foundation for Parkinson’s ...

UC Berkeley Extension

Founded in 1891, UC Berkeley Extension is the continuing education branch of the University of California, Berkeley. Today, Extension offers more than 2,000 courses each year, including online courses, along with more than 70 professional certificates and specialized programs of study. Free and low-cost public events are also frequently held as part of Ext...


More From BioPortfolio on "An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Trea∨derfield=score∨derval=DESC"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks